ArticleJournal of the European Academy of Dermatology and Venereology : JEADV2026
Two-year abrocitinib in atopic dermatitis: Are we reaching the new targets?
Axel De Greef et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
ArticleJournal of the European Academy of Dermatology and Venereology : JEADV2026
Axel De Greef et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.